Concepedia

Publication | Closed Access

Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab

DOI

1.2K

Citations

32

References

2018

Year

David R. Gandara, Sarah Paul, Marcin Kowanetz, Erica Schleifman, Wei Zou, Yan Li, Achim Rittmeyer, Louis Fehrenbacher, Geoff Otto, Christine M. Malboeuf,
Nature Medicine

References

YearCitations

Page 1